LKL International Bhd

LKL International Bhd

0182 · KLSE · Healthcare / Medical Instruments & Supplies

0.03MYR-0.01 (-14.29%)

Price History

Full chart

Market Stats

Previous Close0.035
Open0.03
Day Range0.03 – 0.03
52-Week Range0.03 – 0.06
Volume49.00K
Market Cap13.58M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.06
Dividend Yield0.00%
Beta1.05
50-Day Avg0.0339
200-Day Avg0.0346

About

LKL International Berhad, an investment holding company, engages in the manufacturing of medical and healthcare beds, medical peripherals, and accessories in Malaysia, Africa, Europe, the Middle East, and the rest of Asia. It operates through three segments: Manufacturing, Trading, and Retail. The company offers A&E patient transport trolley, cart and trolley, curtain track, delivery bed, examination table, instrument trolley, manual crank bed, medical chair, nursery equipment, and patient room furniture, as well as hospital electrical bed, hospital hydraulic bed, and hospital ICU and CCU electrical bed; and miscellaneous hospital equipment, such as x-ray viewer, concealment collection table, and surgical bowl stand. It also provides a range of drugs, chemicals, alkalis, cosmetics, personal care, health food, medical device, manure antibodies, and pharmaceutical medicine through its retail pharmacy business; and management and advisory services. In addition, the company is involved in the trading of hospital furniture, laboratory furniture, medical equipment, utensils, and accessories; and property development and general trading. Its products are used in hospitals, medical centers, and other healthcare-related facilities, including clinics and specialist institutions. LKL International Berhad was founded in 1993 and is headquartered in Seri Kembangan, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Lian Seng Ti
  • Employees196
  • HeadquartersWisma LKL, Seri Kembangan, Malaysia, 43300, Malaysia
  • Websitehttps://lklbeds.com

Leadership

  • Mr. Lian Seng TiMD & Director · b. 1968
  • Mr. Pak Hong LimExecutive Director · b. 1986
  • Ms. Pei Fern WongChief Financial Officer · b. 1977
  • Mr. Kah Earng LeeSales Director · b. 1970
  • Ms. Sor Hua TeaCompany Secretary · b. 1971
  • Mui Yee ThienJoint Secretary

Financials

Income Statement

Currency: MYR2016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue37.15M33.89M29.72M37.18M54.95M75.50M85.36M102.48M44.58M47.60M56.46M
Growth (%)--8.76%-12.32%+25.12%+47.80%+37.40%+13.06%+20.05%-56.50%+6.77%+18.62%
Cost of Revenue21.96M17.00M18.78M26.59M35.16M58.34M71.91M87.61M28.56M36.55M45.86M
Gross Profit15.19M16.89M10.93M10.59M19.79M17.17M13.45M14.86M16.02M11.05M10.60M
Gross Margin40.89%49.83%36.80%28.48%36.02%22.73%15.76%14.50%35.94%23.21%18.77%
Operating Expense9.81M10.37M11.71M13.09M13.78M68.62M15.83M35.82M18.23M53.13M32.90M
Operating Income5.38M6.52M-770.62K-2.50M6.01M-51.45M-2.38M-20.96M-2.21M-42.09M-22.30M
Operating Margin14.48%19.25%-2.59%-6.72%10.94%-68.14%-2.79%-20.45%-4.96%-88.42%-39.50%
EBITDA-7.86M1.01M-517.43K8.33M-3.64M-3.26M-34.59M-17.83M
EBITDA Margin-23.19%3.41%-1.39%15.16%-4.27%-7.30%-72.67%-31.59%
Net Income3.27M4.48M-1.10M-2.50M4.30M-51.63M1.14M-20.40M-6.98M-41.29M-26.46M
Net Income Margin8.81%13.22%-3.70%-6.72%7.82%-68.38%1.33%-19.91%-15.65%-86.76%-46.86%
Interest Expense000387.26K405.71K73.80K289.00K0679.92K1.73M2.43M
Interest Expense % of Total Revenue0.00%0.00%0.00%1.04%0.74%0.10%0.34%0.00%1.53%3.64%4.31%

Balance Sheet

Currency: MYR2016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets52.23M72.30M72.40M70.01M79.14M154.21M167.19M150.47M214.97M191.52M160.81M
Total Liabilities17.15M12.52M13.72M13.83M18.66M18.33M16.24M20.40M43.30M61.16M56.25M
Total Equity35.08M59.78M58.68M56.18M60.48M135.88M151.62M130.08M171.66M130.37M105.26M
Cash7.80M18.01M8.44M8.63M5.18M65.66M8.30M14.71M10.99M4.35M14.78M
Total Debt8.47M7.84M7.35M5.89M8.13M6.60M-----
Net Debt----2.93M---17.76M46.25M33.64M

Cash Flow

Currency: MYR2016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow6.60M2.53M-2.35M864.81K-6.98M-21.30M-12.87M-6.08M-16.08M-17.18M-1.31M
Investing Cash Flow-745.51K-6.76M-6.10M-615.23K-519.12K-25.83M--50.90M-46.10M-7.11M-
Financing Cash Flow-2.29M18.93M-713.28K-2.24M-1.35M61.13M-13.74M46.41M17.64M-
Capital Expenditure926.78K6.89M6.42M541.14K1.58M10.93M26.42M20.81M26.00M18.33M3.18M
Free Cash Flow--4.37M-8.77M323.67K-8.75M3.98M-39.29M--42.07M-35.50M-4.49M
Dividends Paid-1.50M0--------
FCF to OCF--172.89%373.63%37.43%125.37%-18.69%305.37%-261.71%206.71%343.79%
Dividend Paid to FCF--34.37%0.00%--------

Earnings

Report DateJul 31, 2016Oct 31, 2016Jan 31, 2017Apr 30, 2017Jul 31, 2017Oct 31, 2017Jan 31, 2018Apr 30, 2018Jul 31, 2018Oct 31, 2018Jan 31, 2019Apr 30, 2019Jul 31, 2019Oct 31, 2019Jan 31, 2020Apr 30, 2020Jul 31, 2020Oct 31, 2020Jan 31, 2021Apr 30, 2021Jul 31, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------
EPS Actual0.030.030.020.00-0.020.010.02-0.030.000.000.00-0.050.000.010.010.060.02-0.020.00-0.06-0.000.000.030.000.01-0.02-0.00-0.030.010.00-0.02-0.01-0.02-0.05-0.01-0.020.01-0.04-0.01-0.01
Surprise----------------------------------------
Timing----------------------------------------

Key Statistics & Ratios

Market Cap13.58M
Enterprise Value51.93M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.26
Price / Book0.14
EPS-0.06
Book Value0.252
Revenue (TTM)52.40M
Gross Profit (TTM)9.44M
EBITDA-14.24M
Profit Margin-41.04%
Operating Margin-25.75%
Return on Equity-20.08%
Return on Assets-7.05%
Shares Outstanding388.08M
Shares Float209.50M
Beta1.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20171×
0.03Apr 3, 2017

Stock Splits

  • Feb 24, 202325:19
  • Oct 13, 20221:10